Literature DB >> 28045374

The role of internal limiting membrane peeling in epiretinal membrane surgery: a randomised controlled trial.

Paris Tranos1, Stavrenia Koukoula1, Davic G Charteris2, Georgia Perganda1, Athanasios Vakalis1, Solon Asteriadis1, Ilias Georgalas3, Petros Petrou2,3.   

Abstract

PURPOSE: To compare the anatomical and functional outcomes after primary idiopathic epiretinal membrane (ERM) peeling with or without internal limiting membrane (ILM) peeling.
DESIGN: A two-centre randomised, controlled clinical trial with 12 months of follow-up.
METHODS: One hundred and two eyes of 102 patients were included in the analysis and were randomised into two groups (ILM peeling (P) and non-ILM peeling (NP) group). Inclusion criteria were: Idiopathic ERM confirmed on optical coherence tomography, age ≥18 years, binocular distortion, best-corrected visual acuity (BCVA) ≤90 ETDRS letters, intraocular pressure ≤23 mm Hg and informed consent. The primary outcome measure was the mean change in the ETDRS distance BCVA at 12 months' follow-up for each group.
RESULTS: The mean change in distance BCVA at 12 months was 0.30±0.24 logMAR (15 ETDRS letters) in the P group and 0.31±0.23 logMAR (14 ETDRS letters) in the NP group, a change that was not statistically significant (p=0.84). No statistically significant differences were observed when comparing the changes in distance BCVA, the changes in metamorphopsia (Amsler grid) and the changes in central retinal thickness between the two groups at any of the time points studied.
CONCLUSIONS: Our analysis suggests that ILM peeling in idiopathic ERM surgery does not result in better visual improvement. The more frequent presence of an uninterrupted interdigitation zone in the P group did not result in a better functional outcome of our patients. No recurrent ERMs were noted in either group. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Retina; Vitreous

Mesh:

Year:  2016        PMID: 28045374     DOI: 10.1136/bjophthalmol-2016-309308

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

Review 1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

Review 2.  Idiopathic epiretinal membrane: progression and timing of surgery.

Authors:  Paul Y Chua; Maria T Sandinha; David H Steel
Journal:  Eye (Lond)       Date:  2021-07-21       Impact factor: 4.456

3.  Comparison of Individual Retinal Layer Thicknesses after Epiretinal Membrane Surgery with or without Internal Limiting Membrane Peeling.

Authors:  Chul Hee Lee; Min Woo Lee; Eun Young Choi; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Sung Chul Lee; Min Kim
Journal:  J Ophthalmol       Date:  2018-10-21       Impact factor: 1.909

4.  With or without internal limiting membrane peeling during idiopathic epiretinal membrane surgery: A meta-analysis.

Authors:  Qinying Huang; Jinying Li
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

5.  Does internal limiting membrane peeling during epiretinal membrane surgery induce microscotomas on microperimetry? Study protocol for PEELING, a randomized controlled clinical trial.

Authors:  Jean-Baptiste Ducloyer; Juliette Ivan; Alexandra Poinas; Olivier Lebreton; Alexandre Bonissent; Paul Fossum; Christelle Volteau; Ramin Tadayoni; Catherine Creuzot-Garchet; Yannick Le Mer; Julien Perol; June Fortin; Anne Chiffoleau; Fanny Billaud; Catherine Ivan; Michel Weber
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

6.  Vitrectomy for the removal of idiopathic epiretinal membrane with or without internal limiting membrane peeling: a meta-analysis.

Authors:  Eleni Christodoulou; Georgios Batsos; Petros Galanis; Christos Kalogeropoulos; Andreas Katsanos; Yannis Alamanos; Maria Stefaniotou
Journal:  Ther Adv Ophthalmol       Date:  2020-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.